Was just highlighting our partnership with SB and how, approaching one year on, we require a a proper update instead of an update saying we are waiting for an update.
An update on MyTomorrow in theory will be next month when the drug is delivered. The company is also submitting a Phase IIb IND for 1102 next quarter. It is an ANP submission but ANP will not be conducting the trial so I am not sure how this affects the approval process.
A 1102 partner should emerge after progress in these two areas. ANP's entire business model is get partners to run trials and commercialize. Let's hope it is a far better deal than 1103.
Why Im excited!, page-62
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.8¢ |
Change
-0.003(3.70%) |
Mkt cap ! $82.67M | |||
| Open | High | Low | Value | Volume |
| 8.1¢ | 8.1¢ | 7.8¢ | $215.5K | 2.715M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 137820 | 7.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 319232 | 3 |
View Market Depth
| Last trade - 15.59pm 19/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |